東華軟件(002065.SZ):東華醫為擬出資5000萬元設東華醫為大數據上海
格隆匯6月14日丨東華軟件(002065.SZ)公佈,公司控股子公司東華醫為科技有限公司擬以自有資金出資人民幣5000萬元對外投資設立“東華醫為大數據上海有限公司”,佔其註冊資本100%。
上海是全國最大的經濟中心城市,長三角世界級城市羣核心城市,為貫徹落實國家“數字中國”和“健康中國”戰略,推動靜安區大數據產業的建設,助力靜安區大健康行業實現全面的數字化升級,公司控股子公司在靜安區設立新公司,一方面通過靜安區管委會提供的良好政策環境和高效服務,利於各項業務的有序開展;基於上海地域優勢,吸引廣大高端研發人才,把握行業前沿信息和趨勢,提升研發能力;另一方面,依託自身在醫療信息化領域的綜合實力,以及在大型醫院信息化建設領域的獨特優勢,全面參與當地智慧醫院、智慧衞健、智慧醫保、智慧養老、互聯網醫療等項目建設,進一步提升公司綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.